Bavdegalutamide is an experimental proteolysis targeting chimera that functions as a androgen receptor degrader.

[1] It is being developed to treat metastatic castration-resistant prostate cancer.

[2][3][4] This drug article relating to the genito-urinary system is a stub.

You can help Wikipedia by expanding it.